|Bid||2.1200 x 3000|
|Ask||2.1800 x 4000|
|Day's Range||2.1050 - 2.2000|
|52 Week Range||1.9500 - 4.9800|
|Beta (5Y Monthly)||1.26|
|PE Ratio (TTM)||3.61|
|Earnings Date||Feb 28, 2023 - Mar 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
BRIDGEWATER, N.J., January 31, 2023--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its fourth quarter and full year 2022 financial results on Thursday March 2, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on March 2, 2023.
Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.
(Bloomberg) -- US health officials have released supplies of the flu drug Tamiflu from a national stockpile as shortages of cold and respiratory medications persist nationwide.Most Read from BloombergElon Musk Fan With 2,900% Gain Sees $1.5 Million Wiped AwayUS Inflation Cools Again, Putting Fed on Track to DownshiftT-Mobile Considers Buying Ryan Reynolds’s Mint MobileThe Document That Separates Biden and TrumpGoogle, Nvidia Express Concerns to FTC About Microsoft’s Activision DealMore than 52,0